Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cowley

Showing results (201-210 of 229) with videos related to

Pageof 23
Sort By:
Science Translational Medicine|August 17, 2012
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4Yin Ren, Hiu Wing Cheung, Geoffrey von Maltzhan, et al.
Nature Communications|June 3, 2020
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factorCarla Eller, Laura Heydmann, Che C Colpitts, et al.
BMC Genomics|May 10, 2011
A comprehensive platform for highly multiplexed mammalian functional genetic screensTroy Ketela, Lawrence E Heisler, Kevin R Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2017
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burdenMeredith L Stone, Katherine B Chiappinelli, Huili Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2018
Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenicMeredith L Stone, Katherine B Chiappinelli, Huili Li, et al.
Cancer Research|June 29, 2017
PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of CancerJessie Hao-Ru Hsu, Benjamin Hubbell-Engler, Guillaume Adelmant, et al.
Cell|December 19, 2012
β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesisJoseph Rosenbluh, Deepak Nijhawan, Andrew G Cox, et al.
Science (New York, N.Y.)|February 26, 2016
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cellsGregory V Kryukov, Frederick H Wilson, Jason R Ruth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in LeiomyosarcomaAdrian Marino-Enriquez, Jan Philipp Novotny, Doga C Gulhan, et al.
Cell|July 29, 2017
Defining a Cancer Dependency MapAviad Tsherniak, Francisca Vazquez, Phil G Montgomery, et al.
Pageof 23

Showing results (201-210 of 229) with videos related to

Sort By:
Pageof 23
Science Translational Medicine|August 17, 2012
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4Yin Ren, Hiu Wing Cheung, Geoffrey von Maltzhan, et al.
Nature Communications|June 3, 2020
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factorCarla Eller, Laura Heydmann, Che C Colpitts, et al.
BMC Genomics|May 10, 2011
A comprehensive platform for highly multiplexed mammalian functional genetic screensTroy Ketela, Lawrence E Heisler, Kevin R Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2017
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burdenMeredith L Stone, Katherine B Chiappinelli, Huili Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2018
Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenicMeredith L Stone, Katherine B Chiappinelli, Huili Li, et al.
Cancer Research|June 29, 2017
PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of CancerJessie Hao-Ru Hsu, Benjamin Hubbell-Engler, Guillaume Adelmant, et al.
Cell|December 19, 2012
β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesisJoseph Rosenbluh, Deepak Nijhawan, Andrew G Cox, et al.
Science (New York, N.Y.)|February 26, 2016
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cellsGregory V Kryukov, Frederick H Wilson, Jason R Ruth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in LeiomyosarcomaAdrian Marino-Enriquez, Jan Philipp Novotny, Doga C Gulhan, et al.
Cell|July 29, 2017
Defining a Cancer Dependency MapAviad Tsherniak, Francisca Vazquez, Phil G Montgomery, et al.
Pageof 23